Early-stage Invasive Breast Cancers: Potential Role of Optical Tomography with US Localization in Assisting Diagnosis

Overview

Journal Radiology

Specialty Radiology

Date 2010 Jun 24

PMID 20571122

Citations 64

Authors

Quing Zhu

Poornima U Hegde

Andrew Ricci Jr

Mark Kane

Edward B Cronin

Yasaman Ardeshirpour

Chen Xu

Andres Aguirre

Scott H Kurtzman

Peter J Deckers

Susan H Tannenbaum

Affiliations

Soon will be listed here.

Abstract

Purpose: To investigate the potential role of optical tomography in the near-infrared (NIR) spectrum with ultrasonographic (US) localization as a means of differentiating early-stage cancers from benign lesions of the breast.

Materials And Methods: The protocol was approved by the institutional review boards and was HIPAA compliant; all participants signed an informed consent. One hundred seventy-eight consecutive women (mean age, 52 years; range, 21-89 years) who underwent US-guided biopsy were imaged with a hand-held probe consisting of a coregistered US transducer and an NIR imager. The lesion location provided by coregistered US was used to guide optical imaging. Light absorption was measured at two optical wavelengths. From this measurement, tumor angiogenesis was assessed on the basis of calculated total hemoglobin concentration (tHb) and was correlated with core biopsy results. For patients diagnosed with carcinomas and followed up with subsequent excision, the tHb was correlated with pathologic parameters.

Results: There were two in situ carcinomas (Tis), 35 T1 carcinomas, 24 T2-T4 carcinomas, and 114 benign lesions. The mean maximum and mean average tHb of the Tis-T1 group were 102.0 micromol/L +/- 28.5 (standard deviation) and 71.9 micromol/L +/- 18.8, and those of the T2-T4 group were 100.3 micromol/L +/- 26.4 and 67.0 micromol/L +/- 18.3, respectively. The mean maximum and mean average tHb of the benign group were 55.1 micromol/L +/- 22.7 and 39.1 micromol/L +/- 14.9, respectively. Both mean maximum and mean average tHb levels were significantly higher in the malignant groups than they were in the benign group (P < .001). The sensitivity, specificity, positive predictive value, and negative predictive value for Tis-T1 cancers were 92%, 93%, 81%, and 97%. The corresponding values for T2-T4 tumors were 75%, 93%, 69%, and 95%.

Conclusion: The angiogenesis (tHb) contrast imaged by using the NIR technique with US holds promise as an adjunct to mammography and US for distinguishing early-stage invasive breast cancers from benign lesions.

Citing Articles

Widefield ultra-high-density optical breast tomography system supplementing x-ray mammography.

Mireles M, Xu E, Vanegas M, Muldoon A, Ragunathan R, Yan S Sci Rep. 2025; 15(1):8732.

PMID: 40082492 PMC: 11906649. DOI: 10.1038/s41598-025-92261-9.

Optimizing breast cancer diagnosis with photoacoustic imaging: An analysis of intratumoral and peritumoral radiomics.

Huang Z, Mo S, Wu H, Kong Y, Luo H, Li G Photoacoustics. 2024; 38:100606.

PMID: 38665366 PMC: 11044033. DOI: 10.1016/j.pacs.2024.100606.

Self-Guided Algorithm for Fast Image Reconstruction in Photo-Magnetic Imaging: Artificial Intelligence-Assisted Approach.

Algarawi M, Saraswatula J, Pathare R, Zhang Y, Shah G, Eresen A Bioengineering (Basel). 2024; 11(2).

PMID: 38391612 PMC: 10886351. DOI: 10.3390/bioengineering11020126.

Automated pipeline for breast cancer diagnosis using US assisted diffuse optical tomography.

Xue M, Zhang M, Li S, Zou Y, Zhu Q Biomed Opt Express. 2023; 14(11):6072-6087.

PMID: 38021111 PMC: 10659805. DOI: 10.1364/BOE.502244.

Optical Breast Imaging: A Review of Physical Principles, Technologies, and Clinical Applications.

Poplack S, Park E, Ferrara K J Breast Imaging. 2023; 5(5):520-537.

PMID: 37981994 PMC: 10655724. DOI: 10.1093/jbi/wbad057.

References

Collins L, Baer H, Tamimi R, Connolly J, Colditz G, Schnitt S . Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study. Cancer. 2006; 109(2):180-7. DOI: 10.1002/cncr.22408. View

Roubidoux M, Sabel M, Bailey J, Kleer C, Klein K, Helvie M . Small (< 2.0-cm) breast cancers: mammographic and US findings at US-guided cryoablation--initial experience. Radiology. 2004; 233(3):857-67. DOI: 10.1148/radiol.2333031734. View

Corsetti V, Houssami N, Ferrari A, Ghirardi M, Bellarosa S, Angelini O . Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost. Eur J Cancer. 2008; 44(4):539-44. DOI: 10.1016/j.ejca.2008.01.009. View

Heffer E, Pera V, Schutz O, Siebold H, Fantini S . Near-infrared imaging of the human breast: complementing hemoglobin concentration maps with oxygenation images. J Biomed Opt. 2004; 9(6):1152-60. DOI: 10.1117/1.1805552. View

Zhu Q, Tannenbaum S, Hegde P, Kane M, Xu C, Kurtzman S . Noninvasive monitoring of breast cancer during neoadjuvant chemotherapy using optical tomography with ultrasound localization. Neoplasia. 2008; 10(10):1028-40. PMC: 2546597. DOI: 10.1593/neo.08602. View

Zhu Q, Chen N, Kurtzman S . Imaging tumor angiogenesis by use of combined near-infrared diffusive light and ultrasound. Opt Lett. 2003; 28(5):337-9. PMC: 1533768. DOI: 10.1364/ol.28.000337. View

Leff D, Warren O, Enfield L, Gibson A, Athanasiou T, Patten D . Diffuse optical imaging of the healthy and diseased breast: a systematic review. Breast Cancer Res Treat. 2007; 108(1):9-22. DOI: 10.1007/s10549-007-9582-z. View

Roubidoux M, Bailey J, Wray L, Helvie M . Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors. Radiology. 2003; 230(1):42-8. DOI: 10.1148/radiol.2301020589. View

Poplack S, Tosteson T, Wells W, Pogue B, Meaney P, Hartov A . Electromagnetic breast imaging: results of a pilot study in women with abnormal mammograms. Radiology. 2007; 243(2):350-9. DOI: 10.1148/radiol.2432060286. View

10.

Lamb P, Perry N, Vinnicombe S, Wells C . Correlation between ultrasound characteristics, mammographic findings and histological grade in patients with invasive ductal carcinoma of the breast. Clin Radiol. 2000; 55(1):40-4. DOI: 10.1053/crad.1999.0333. View

11.

Xu C, Yuan B, Zhu Q . Optimal probe design for breast imaging using near-infrared diffused light. J Biomed Opt. 2008; 13(4):044002. PMC: 2597060. DOI: 10.1117/1.2966703. View

12.

Corsetti V, Ferrari A, Ghirardi M, BERGONZINI R, Bellarosa S, Angelini O . Role of ultrasonography in detecting mammographically occult breast carcinoma in women with dense breasts. Radiol Med. 2006; 111(3):440-8. DOI: 10.1007/s11547-006-0040-5. View

13.

Zhu Q, Kurtzma S, Hegde P, Tannenbaum S, Kane M, Huang M . Utilizing optical tomography with ultrasound localization to image heterogeneous hemoglobin distribution in large breast cancers. Neoplasia. 2005; 7(3):263-70. PMC: 1501132. DOI: 10.1593/neo.04526. View

14.

Stavros A, Thickman D, Rapp C, Dennis M, Parker S, Sisney G . Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology. 1995; 196(1):123-34. DOI: 10.1148/radiology.196.1.7784555. View

15.

Viacava P, Naccarato A, Bocci G, Fanelli G, Aretini P, Lonobile A . Angiogenesis and VEGF expression in pre-invasive lesions of the human breast. J Pathol. 2004; 204(2):140-6. DOI: 10.1002/path.1626. View

16.

Agrawal G, Su M, Nalcioglu O, Feig S, Chen J . Significance of breast lesion descriptors in the ACR BI-RADS MRI lexicon. Cancer. 2009; 115(7):1363-80. PMC: 2748779. DOI: 10.1002/cncr.24156. View

17.

Taylor K, Merritt C, Piccoli C, Schmidt R, Rouse G, Fornage B . Ultrasound as a complement to mammography and breast examination to characterize breast masses. Ultrasound Med Biol. 2002; 28(1):19-26. DOI: 10.1016/s0301-5629(01)00491-4. View

18.

Vaupel P, Kallinowski F, Okunieff P . Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 1989; 49(23):6449-65. View

19.

Worsham M, Raju U, Lu M, Kapke A, Cheng J, Wolman S . Multiplicity of benign breast lesions is a risk factor for progression to breast cancer. Clin Cancer Res. 2007; 13(18 Pt 1):5474-9. DOI: 10.1158/1078-0432.CCR-07-0928. View

20.

Cerussi A, Hsiang D, Shah N, Mehta R, Durkin A, Butler J . Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy. Proc Natl Acad Sci U S A. 2007; 104(10):4014-9. PMC: 1805697. DOI: 10.1073/pnas.0611058104. View